Abstract: An object of the present invention is to provide a logic integrated circuit that increases reliability of configuration information held in a switch while maintaining high tamper resistance and a small chip area. The logic integrated circuit according to the present invention includes: a three-terminal resistance change switch including a first resistance change switch and a second resistance change switch connected in series; a reading circuit which reads first data based on a resistance state of the first resistance change switch and second data based on a resistance state of the second resistance change switch; and a first error detection circuit which compares the first data with the second data and issue an output based on a result of the comparison.

Abstract: The purpose of the present invention is to increase the efficiency with which silicon on a chip is used, and to easily reduce the size of a logic cell. To accomplish the purpose, this reconfigurable circuit includes: a logic memory unit configured from a resistance change element, and positioned distributed into at least two units; a logic unit for referencing the logic memory unit and performing logical operations; and a signal path switching unit for receiving the results of the logical operation of the logic unit and outputting said results to the outside. The logic memory part and the signal path switching part constitute part of a crossbar switching circuit, and share write wiring to the resistance change element.

Abstract: A reconfigurable circuit includes first and second wires and two or more paths active at different times. Each path includes: a first NVRS whose first terminal is connected to the first wire; a first transistor whose drain terminal is connected to a second terminal of the first NVRS; a second NVRS whose first terminal is connected to the second terminal of the first NVRS; a second transistor whose source terminal is connected to a second terminal of the second NVRS and whose drain terminal is connected to the second wire; and a 2-input AND circuit whose output is connected to a gate terminal of the first transistor. A time control signal is supplied to a first input of the 2-input AND circuit and a gate terminal of the second transistor. A write control signal is supplied to a second input of the 2-input AND circuit.

Abstract: The present invention relates to a novel phenanthroline phosphonic acid compound and a pharmaceutical salt thereof, as well as an application of the compound and the pharmaceutical salt thereof as collagen prolyl hydroxylase inhibitors in the preparation of drugs for preventing or treating collagen prolyl-4-hydroxylase related disease.

Abstract: A reconfigurable circuit comprising: a first level crossbar switch that has first non-volatile resistive switches; a second level crossbar switch that has second non-volatile resistive switches; and a first wire and third non-volatile resistive switches that are used for redundancy, wherein input wires of the second level crossbar switch are connected to output wires of the first level crossbar switch one-to-one, and input wires of the first level crossbar switch and output wires of the second level crossbar switch are connected to the first wire through the third non-volatile resistive switches.

Abstract: The invention is to provide a compact reconfigurable circuit implementing a LUT and a “hard” circuit. The present invention provides a reconfigurable circuit comprising: first wires disposed in a first direction; a second wire disposed in a second direction intersecting the first direction; a power line, a ground line and data input line or data input inverse line coupled to the said first wires one-to-one; a multiplexer, one of whose inputs is connected with the second wire; nonvolatile switch cells utilized to interconnect the first wires and second wire at the crosspoints, wherein every nonvolatile switch cell is constructed by at least one non-volatile resistive switch.

Abstract: Provided is a programmable logic integrated circuit wherein even if a failure occurs in any resistance-variable element, remedy would be possible and hence the improvement of reliability has been achieved. In a programmable logic integrated circuit comprising resistance-variable elements, when the states of the resistance-variable elements are to be changed according to externally inputted configuration information, a control means uses a reading means to read the states of the respective resistance-variable elements, and then uses a writing means to change only the states of resistance-changing elements that are different from a state indicated by the configuration information.

Abstract: A reconfigurable circuit comprising: a first level crossbar switch that has first non-volatile resistive switches; a second level crossbar switch that has second non-volatile resistive switches; and a first wire and third non-volatile resistive switches that are used for redundancy, wherein input wires of the second level crossbar switch are connected to output wires of the first level crossbar switch one-to-one, and input wires of the first level crossbar switch and output wires of the second level crossbar switch are connected to the first wire through the third non-volatile resistive switches.

Abstract: The invention is to provide a compact reconfigurable circuit implementing a LUT and a “hard” circuit. The present invention provides a reconfigurable circuit comprising: first wires disposed in a first direction; a second wire disposed in a second direction intersecting the first direction; a power line, a ground line and data input line or data input inverse line coupled to the said first wires one-to-one; a multiplexer, one of whose inputs is connected with the second wire; nonvolatile switch cells utilized to interconnect the first wires and second wire at the crosspoints, wherein every nonvolatile switch cell is constructed by at least one non-volatile resistive switch.

Abstract: A purpose of the invention is to provide a crossbar switch for reducing the layout areas of a crossbar switch and peripheral circuits thereof. A crossbar switch of the invention comprises: a plurality of first wires extending in a first direction; a plurality of second wires extending in a second direction; a plurality of third wires extending in a third direction; a plurality of fourth wires extending in a fourth direction; and a plurality of switch cells connected to the first and second wires. The first wires are skew relative to the second and fourth wires, while the third wires are skew relative to the second and fourth wires. The switch cells are connected to the third and fourth wires, and further, the third wires are also connected to the switch cells connected to the first wires adjacent to the respective first wires; or alternatively, further, the fourth wires are also connected to the switch cells connected to the second wires adjacent to the respective second wires.

Abstract: The present invention relates to a novel phenanthroline phosphonic acid compound and a pharmaceutical salt thereof, as well as an application of the compound and the pharmaceutical salt thereof as collagen prolyl hydroxylase inhibitors in the preparation of drugs for preventing or treating collagen prolyl-4-hydroxylase related disease.

Abstract: Disclosed are an axial flow type dust collector and a pre-collecting device for the same. The axial flow type dust collector includes: a front pre-processing section and a back post-processing section and a gas flow unit configured to include a cone-shaped diverging section for diverging flow of dirty gas introduced through an inlet and a cone-shaped converging section installed in a down stream of the cone-shaped diverging section and converging the flow of the dirty gas on a transfer tube. With these configurations, the axial flow type dust collector can be used only by pre-processing section removable, can be used as a one-piece together with it, and the loss of static pressure is small and it is easy to manage, and high collection efficiency is provided by the dust collector.

Abstract: This invention relates generally to tetracyclic tetrahydroquinoline compounds, and analogues thereof, and pharmaceutically acceptable salt forms thereof, which are selective inhibitors of serine protease enzymes, especially factor VIIa; pharmaceutical compositions containing the same; and methods of using the same as anticoagulant agents for modulation of the coagulation cascade.

Abstract: The present invention provides methods and compositions for treating infectious disease or suppressing inflammation associated therewith or ameliorating symptoms thereof by the suppression of the activity of a member of the interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family of proteases. Also provided are compositions useful for these purposes. Exemplary compounds useful in the methods of the invention are provided herein.

Abstract: The present invention provides methods and compositions for preventing and treating inflammation-associated disorders or ameliorating symptoms thereof by the suppression of the activity of a member of the interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family of proteases. Also provided are compositions useful for these purposes. Exemplary compounds useful in the methods of the invention are provided herein.

Abstract: This invention relates generally to tetracyclic tetrahydroquinoline compounds, and analogues thereof, and pharmaceutically acceptable salt forms thereof, which are selective inhibitors of serine protease enzymes, especially factor VIIa; pharmaceutical compositions containing the same; and methods of using the same as anticoagulant agents for modulation of the coagulation cascade.

Abstract: The present invention provides methods and compositions for treating infectious disease or suppressing inflammation associated therewith or ameliorating symptoms thereof by the suppression of the activity of a member of the interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family of proteases. Also provided are compositions useful for these purposes. Exemplary compounds useful in the methods of the invention are provided herein.

Abstract: The present invention provides methods and compositions for treating infectious disease or suppressing inflammation associated therewith or ameliorating symptoms thereof by the suppression of the activity of a member of the interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family of proteases. Also provided are compositions useful for these purposes. Exemplary compounds useful in the methods of the invention are provided herein.

Abstract: This invention is directed to novel (N-substituted) indole ICE/ced-3-inhibitor compounds. The invention is also directed to pharmaceutical compositions of such indole compounds, plus the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury.

Abstract: The present invention provides methods for expanding and increasing survival of hematopoietic cell populations, for prolonging viability of an organ for transplantation, and enhancing bioproduction, using interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family inhibitors. Exemplary compounds useful in the methods of the invention are provided herein.